STATE-OF-THE-ART PAPER
Vitamin D DeficiencyAn Important, Common, and Easily Treatable Cardiovascular Risk Factor?
John H. Lee, MD*,
James H. O'Keefe, MD*,*,
David Bell, MD ,
Donald D. Hensrud, MD, MPH and
Michael F. Holick, MD, PhD
* Mid America Heart Institute and University of Missouri, Kansas City, Missouri
Southside Endocrinology, Birmingham, Alabama
Mayo Clinic, Rochester, Minnesota
Boston University Medical Center, Boston, Massachusetts
Manuscript received June 4, 2008;
revised manuscript received August 6, 2008,
accepted August 13, 2008.
* Reprint requests and correspondence: Dr. James H. O'Keefe, 4330 Wornall Road, Suite 2000, Kansas City, Missouri 64111 (Email: jhokeefe{at}cc-pc.com).
Vitamin D deficiency is a highly prevalent condition, present in approximately 30% to 50% of the general population. A growing body of data suggests that low 25-hydroxyvitamin D levels may adversely affect cardiovascular health. Vitamin D deficiency activates the renin-angiotensin-aldosterone system and can predispose to hypertension and left ventricular hypertrophy. Additionally, vitamin D deficiency causes an increase in parathyroid hormone, which increases insulin resistance and is associated with diabetes, hypertension, inflammation, and increased cardiovascular risk. Epidemiologic studies have associated low 25-hydroxyvitamin D levels with coronary risk factors and adverse cardiovascular outcomes. Vitamin D supplementation is simple, safe, and inexpensive. Large randomized controlled trials are needed to firmly establish the relevance of vitamin D status to cardiovascular health. In the meanwhile, monitoring serum 25-hydroxyvitamin D levels and correction of vitamin D deficiency is indicated for optimization of musculoskeletal and general health.
Key Words: vitamin D 25-hydroxyvitamin D calcium coronary disease prevention hypertension diabetes
|
Abbreviations and Acronyms
| | 25(OH)D = 25-hydroxyvitamin D | | CV = cardiovascular | | MI = myocardial infarction | | PTH = parathyroid hormone | | UVB = ultraviolet B | | VDR = vitamin D receptor |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
O. Gezmish, M. Tare, H. C. Parkington, R. Morley, E. R. Porrello, K. J. Bubb, and M. J. Black
Maternal Vitamin D Deficiency Leads to Cardiac Hypertrophy in Rat Offspring
Reproductive Sciences,
February 1, 2010;
17(2):
168 - 176.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fiscella and P. Franks
Vitamin D, Race, and Cardiovascular Mortality: Findings From a National US Sample
Ann. Fam. Med,
January 1, 2010;
8(1):
11 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vikman, R. M. Brena, P. Armstrong, J. Hartiala, C. B. Stephensen, and H. Allayee
Functional analysis of 5-lipoxygenase promoter repeat variants
Hum. Mol. Genet.,
December 1, 2009;
18(23):
4521 - 4529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Mattson-DiCecca, E. E. Reynolds, and J. R. Cummings
Update: A 55-Year-Old Woman With Osteopenia
JAMA,
November 11, 2009;
302(18):
2023 - 2024.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Lenz
Vitamin D Supplementation and Cancer Prevention
American Journal of Lifestyle Medicine,
September 1, 2009;
3(5):
365 - 368.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. B. GRANT and B. J. BOUCHER
Current Impediments to Acceptance of the Ultraviolet-B-Vitamin D-Cancer Hypothesis
Anticancer Res,
September 1, 2009;
29(9):
3597 - 3604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. O'Keefe, M. D. Carter, and C. J. Lavie
Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach
Mayo Clin. Proc.,
August 1, 2009;
84(8):
741 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Scragg, R. Thadhani, and C. A. Camargo Jr
Association Between Altitude and Mortality in Incident Dialysis Patients
JAMA,
June 17, 2009;
301(23):
2442 - 2443.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Becker, R. Y. Gordon, S. C. Halbert, B. French, P. B. Morris, and D. J. Rader
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
Ann Intern Med,
June 16, 2009;
150(12):
830 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pilz and A. Tomaschitz
Vitamin D deficiency and myocardial dysfunction.
J. Am. Coll. Cardiol.,
May 26, 2009;
53(21):
2011 - 2011.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. O'Keefe, J. H. Lee, D. S.H. Bell, and M. F. Holick
Reply
J. Am. Coll. Cardiol.,
May 26, 2009;
53(21):
2012 - 2013.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian
Vitamin D, outdoor happiness, and the meaning of deficiency.
J. Am. Coll. Cardiol.,
May 26, 2009;
53(21):
2011 - 2012.
[Full Text]
[PDF]
|
 |
|
|